Study of Individualized Amonafide to Treat Prostate Cancer
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of Amonafide in men with
androgen-independent prostate cancer, assigned to individualized doses of Amonafide based on
acetylator phenotype information (doses adjusted on individual metabolism).